Seizure Disorders
📧 Sign up to get email alerts when something new happens for Seizure Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Update: Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures [Phase 3]
A Phase 3 clinical trial evaluates cenobamate for safety and efficacy in pediatric subjects aged 2-17 with partial-onset seizures; study sta…
-
FDA approval · 2026-08-10FDA Approved: BRIVARACETAM — Original Application (Aurobindo Pharma Limited)
FDA approval overview for the generic anticonvulsant brivaracetam marketed by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures [Phase 3]
This Phase 3 trial is evaluating the safety and tolerability of Staccato Alprazolam in participants 12 years and older with stereotypical pr…
-
FDA approval · 2026-04-08FDA Approved: LEVETIRACETAM SOLUTION — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for LEVETIRACETAM SOLUTION from Chartwell RX, LLC, granting approval under the ANDA process.
-
FDA approval · 2025-11-14FDA Approved: DIAZEPAM — Original Application (Navinta LLC)
FDA approved Navinta LLC's generic diazepam through an Original Application (ANDA 217468).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-03-05FDA Approved: LEVETIRACETAM IN SODIUM CHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for levetiracetam in sodium chloride, a new injectable formulation by Hikma Pharmaceuticals USA Inc.…
-
FDA approval · 2025-02-25FDA Approved: LEVETIRACETAM — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for an oral generic formulation of levetiracetam. This approval enables Camber…
-
FDA approval · 2024-12-17FDA Approved: DIAZEPAM — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved a supplemental application for diazepam submitted by Lupin Pharmaceuticals, Inc. The approval relates to changes under the appr…
-
FDA approval · 2024-12-16FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for diazepam from Hikma Pharmaceuticals USA Inc., updating the approval status of this generic produ…
-
FDA approval · 2024-10-17FDA Approved: CLORAZEPATE DIPOTASSIUM — Supplemental Application (NORTHSTAR RX LLC)
FDA approved a supplemental application for clorazepate dipotassium submitted by NorthStar RX LLC.
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Epilepsy Learning Healthcare System (ELHS)
A study update for the Epilepsy Learning Healthcare System (ELHS) sponsored by the Epilepsy Foundation of America, currently recruiting to i…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System. [NA]
Clinical trial update on NCT06027749 evaluating ultra-long-term ambulatory EEG monitoring with a remote EEG system to capture ictal events i…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Statistical Analysis of Prevalence, Incidence, Comorbidities and Medical Expense in Epileptic Children in Taiwan Based on National Health Research Insurance Database.
A completed observational study analyzing the prevalence, incidence, comorbidities, and medical expenses of pediatric epilepsy in Taiwan usi…
-
FDA approval · 2024-07-05FDA Approved: LEVETIRACETAM — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Levetiracetam from Micro Labs Limited.
-
FDA approval · 2024-04-24FDA Approved: LACOSAMIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for lacosamide submitted by Ascend Laboratories, LLC, signaling a regulatory action on this generic …
-
FDA approval · 2024-01-23FDA Approved: PRIMIDONE — Original Application (Carnegie Pharmaceuticals LLC)
FDA approved the original ANDA for primidone from Carnegie Pharmaceuticals LLC. Primidone is an anticonvulsant used in the treatment of cert…
-
FDA approval · 2023-09-26FDA Approved: DIVALPROEX SODIUM — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original ANDA for divalproex sodium, providing a generic option for this anticonvulsant/mood stabilizer…
-
FDA approval · 2023-09-25FDA Approved: LORAZEPAM — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for lorazepam submitted by Hospira, Inc. under ANDA 074243.
-
FDA approval · 2023-05-23FDA Approved: LEVETIRACETAM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application to authorize Levetiracetam in sodium chloride for intravenous use, manufactured by Eugia US LLC.
-
FDA approval · 2023-05-22FDA Approved: LEVETIRACETAM — Supplemental Application (Major Pharmaceuticals)
FDA supplemental application approval for levetiracetam (Major Pharmaceuticals) under ANDA201157.
-
FDA approval · 2023-03-01FDA Approved: OXCARBAZEPINE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for oxcarbazepine filed by Amneal Pharmaceuticals LLC.
-
FDA approval · 2023-02-08FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approves a supplemental application for Diazepam by Natco Pharma USA LLC, approving a supplemental change to the generic diazepam produc…
-
FDA approval · 2023-01-17FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Diazepam from Hikma Pharmaceuticals USA Inc., indicating an update to an existing Diazepam produ…
-
FDA approval · 2023-01-13FDA Approved: VALIUM — Supplemental Application (Roche Laboratories Inc.)
The FDA approved a supplemental application for Valium (diazepam) from Roche Laboratories Inc., updating the existing NDA.
-
FDA approval · 2022-11-17FDA Approved: SEZABY — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved SEZABY (phenobarbital sodium) from Sun Pharmaceutical Industries via an original NDA. It is an anticonvulsant indicated for sei…